Publisher Correction: CRAFITY score as a predictive marker for refractoriness to atezolizumab plus bevacizumab therapy in hepatocellular carcinoma: a multicenter retrospective study
1 Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan.
2 Department of Gastroenterology and Hepatology, Kurashiki Central Hospital, Kurashiki, Japan.
3 Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan. [email protected].
4 Department of Gastroenterology and Hepatology, Osaka Red Cross Hospital, Osaka, Japan.
5 Department of Gastroenterology and Hepatology, Meiwa Hospital, Nishinomiya, Japan.
6 Department of Gastroenterology, Kyoto Medical Center, Kyoto, Japan.
7 Department of Gastroenterology and Hepatology, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, Japan.
8 Department of Gastroenterology and Hepatology, Japanese Red Cross Wakayama Medical Center, Wakayama, Japan.
9 Department of Health Informatics, Graduate School of Medicine and School of Public Health, Kyoto University, Kyoto, Japan.
10 Department of Gastroenterology and Hepatology, Kyoto Katsura Hospital, Kyoto, Japan.
11 Department of Medical Oncology, Shiga General Hospital, Moriyama, Japan.
12 Department of Gastroenterology and Hepatology, Shiga General Hospital, Moriyama, Japan.
13 Division of Cancer Immunotherapy, Center for Cancer Immunotherapy and Immunobiology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
14 Division of Hepato-Biliary-Pancreatic Surgery and Transplantation, Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.